Integrins as Therapeutic Targets for SARS-CoV-2

Detalles Bibliográficos
Autores principales: Gressett, Timothy E., Nader, Danielle, Robles, Juan Pablo, Buranda, Tione, Kerrigan, Steven W., Bix, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128570/
https://www.ncbi.nlm.nih.gov/pubmed/35619646
http://dx.doi.org/10.3389/fcimb.2022.892323
_version_ 1784712583593328640
author Gressett, Timothy E.
Nader, Danielle
Robles, Juan Pablo
Buranda, Tione
Kerrigan, Steven W.
Bix, Gregory
author_facet Gressett, Timothy E.
Nader, Danielle
Robles, Juan Pablo
Buranda, Tione
Kerrigan, Steven W.
Bix, Gregory
author_sort Gressett, Timothy E.
collection PubMed
description
format Online
Article
Text
id pubmed-9128570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91285702022-05-25 Integrins as Therapeutic Targets for SARS-CoV-2 Gressett, Timothy E. Nader, Danielle Robles, Juan Pablo Buranda, Tione Kerrigan, Steven W. Bix, Gregory Front Cell Infect Microbiol Cellular and Infection Microbiology Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9128570/ /pubmed/35619646 http://dx.doi.org/10.3389/fcimb.2022.892323 Text en Copyright © 2022 Gressett, Nader, Robles, Buranda, Kerrigan and Bix https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Gressett, Timothy E.
Nader, Danielle
Robles, Juan Pablo
Buranda, Tione
Kerrigan, Steven W.
Bix, Gregory
Integrins as Therapeutic Targets for SARS-CoV-2
title Integrins as Therapeutic Targets for SARS-CoV-2
title_full Integrins as Therapeutic Targets for SARS-CoV-2
title_fullStr Integrins as Therapeutic Targets for SARS-CoV-2
title_full_unstemmed Integrins as Therapeutic Targets for SARS-CoV-2
title_short Integrins as Therapeutic Targets for SARS-CoV-2
title_sort integrins as therapeutic targets for sars-cov-2
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128570/
https://www.ncbi.nlm.nih.gov/pubmed/35619646
http://dx.doi.org/10.3389/fcimb.2022.892323
work_keys_str_mv AT gressetttimothye integrinsastherapeutictargetsforsarscov2
AT naderdanielle integrinsastherapeutictargetsforsarscov2
AT roblesjuanpablo integrinsastherapeutictargetsforsarscov2
AT burandatione integrinsastherapeutictargetsforsarscov2
AT kerriganstevenw integrinsastherapeutictargetsforsarscov2
AT bixgregory integrinsastherapeutictargetsforsarscov2

Ejemplares similares